Mihaela Popa

1.2k total citations
25 papers, 507 citations indexed

About

Mihaela Popa is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mihaela Popa has authored 25 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Hematology. Recurrent topics in Mihaela Popa's work include Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (4 papers) and Ultrasound and Hyperthermia Applications (4 papers). Mihaela Popa is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (4 papers) and Ultrasound and Hyperthermia Applications (4 papers). Mihaela Popa collaborates with scholars based in Norway, United States and France. Mihaela Popa's co-authors include Emmet McCormack, Bjørn Tore Gjertsen, Spiros Kotopoulis, Odd Helge Gilja, Georg Dimcevski, Veronika Mamaeva, Anne M. Øyan, Yi Qu, Xisong Ke and Karl‐Henning Kalland and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Mihaela Popa

24 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mihaela Popa Norway 13 195 186 123 107 85 25 507
Yangmeihui Song China 14 196 1.0× 153 0.8× 145 1.2× 83 0.8× 55 0.6× 27 498
Motomu Kuroki Japan 11 224 1.1× 161 0.9× 129 1.0× 89 0.8× 89 1.0× 13 561
Dennis Doleschel Germany 11 148 0.8× 257 1.4× 169 1.4× 49 0.5× 71 0.8× 17 678
Zhaoze Guo China 12 223 1.1× 136 0.7× 148 1.2× 127 1.2× 54 0.6× 28 497
Gianfranco Baronzio Italy 10 112 0.6× 149 0.8× 62 0.5× 66 0.6× 25 0.3× 23 354
Katherine D. Castle United States 11 137 0.7× 89 0.5× 101 0.8× 84 0.8× 28 0.3× 13 401
Yuzhen Yin China 13 182 0.9× 124 0.7× 190 1.5× 83 0.8× 28 0.3× 34 520
Caterina Malcontenti‐Wilson Australia 13 112 0.6× 97 0.5× 107 0.9× 64 0.6× 19 0.2× 21 426

Countries citing papers authored by Mihaela Popa

Since Specialization
Citations

This map shows the geographic impact of Mihaela Popa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihaela Popa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihaela Popa more than expected).

Fields of papers citing papers by Mihaela Popa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihaela Popa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihaela Popa. The network helps show where Mihaela Popa may publish in the future.

Co-authorship network of co-authors of Mihaela Popa

This figure shows the co-authorship network connecting the top 25 collaborators of Mihaela Popa. A scholar is included among the top collaborators of Mihaela Popa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihaela Popa. Mihaela Popa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popa, Mihaela, et al.. (2025). The Accuracy of Biparametric Prostate MRI in the Pathway of Patients With Prostate Cancer. Cureus. 17(5). e83663–e83663.
3.
Kaspers, Jorn, Mihaela Popa, Alex Karlsson‐Parra, et al.. (2024). Vididencel, a Leukemia-Derived Dendritic Cell Vaccine, Acts Synergistically with Azacitidine/Venetoclax Treatment in a Preclinical AML Model. Blood. 144(Supplement 1). 2062–2062. 1 indexed citations
4.
Kotopoulis, Spiros, Christina Lam, Sofie Snipstad, et al.. (2022). Formulation and characterisation of drug-loaded antibubbles for image-guided and ultrasound-triggered drug delivery. Ultrasonics Sonochemistry. 85. 105986–105986. 29 indexed citations
5.
Eikrem, Øystein, Spiros Kotopoulis, Mihaela Popa, et al.. (2021). Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys. Pharmaceutics. 13(12). 2038–2038. 4 indexed citations
6.
Zhang, Juan, Mihaela Popa, Marcus J.G.W. Ladds, et al.. (2021). DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance. iScience. 24(5). 102494–102494. 15 indexed citations
7.
Popa, Mihaela, et al.. (2021). Xenograft Models of Ovarian Cancer for Therapy Evaluation. Methods in molecular biology. 2424. 275–293. 3 indexed citations
8.
Garibay, Gorka Ruíz de, Mihaela Popa, Ben Davidson, et al.. (2021). Repurposing 18F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy. Theranostics. 11(12). 6044–6057. 8 indexed citations
9.
Bischof, Katharina, Mihaela Popa, Lars A. Akslen, et al.. (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. EBioMedicine. 56. 102782–102782. 14 indexed citations
10.
Ladds, Marcus J.G.W., Ingeborg M.M. van Leeuwen, Kai Er Eng, et al.. (2018). Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib. PLoS ONE. 13(4). e0195956–e0195956. 4 indexed citations
11.
Andresen, Vibeke, H. G. MUKHERJEE, André Sulen, et al.. (2016). Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death and Disease. 7(12). e2497–e2497. 25 indexed citations
12.
Kotopoulis, Spiros, Mihaela Popa, Andrew Healey, et al.. (2016). Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma. Journal of Controlled Release. 245. 70–80. 29 indexed citations
13.
Popa, Mihaela, et al.. (2016). The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer. PLoS ONE. 11(6). e0158208–e0158208. 31 indexed citations
14.
Gélébart, Pascal, Mihaela Popa, & Emmet McCormack. (2015). Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.. Current Pharmaceutical Biotechnology. 17(1). 42–51. 5 indexed citations
15.
Haldorsen, Ingfrid S., Mihaela Popa, Njål Brekke, et al.. (2015). Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma. PLoS ONE. 10(8). e0135220–e0135220. 31 indexed citations
16.
Popa, Mihaela, Olav Karsten Vintermyr, Anders Molven, et al.. (2014). First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma. PLoS ONE. 9(3). e89527–e89527. 19 indexed citations
17.
Qu, Yi, Anne M. Øyan, Runhui Liu, et al.. (2013). Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling. Cancer Research. 73(23). 7090–7100. 61 indexed citations
18.
Kotopoulis, Spiros, Anthony Delalande, Mihaela Popa, et al.. (2013). Sonoporation-Enhanced Chemotherapy Significantly Reduces Primary Tumour Burden in an Orthotopic Pancreatic Cancer Xenograft. Molecular Imaging and Biology. 16(1). 53–62. 109 indexed citations
19.
Jordheim, Lars Petter, Mihaela Popa, André Sulen, et al.. (2013). Abstract 3274: Combination of elacytarabine and daunorubicin is significantly more effective than combination of cytarabine and daunorubicin in primary patient xenografts of AML.. Cancer Research. 73(8_Supplement). 3274–3274. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026